Plasma Fibroblast Growth Factor-23 Level and its Relation to Carotid Artery Atherosclerosis in Hemodialysis Patients

Faculty Medicine Year: 2017
Type of Publication: ZU Hosted Pages:
Authors:
Ibrahiem Mohamed Ibrahim Salem
Journal: Urology & Nephrology Open Access Journal MedCrave Volume:
Keywords : Plasma Fibroblast Growth Factor-23 Level , , Relation    
Abstract:
Background: Abnormalities in bone metabolism are a prevalent condition in CKD patients. FGF23 has been suggested to play a role in vascular calcification in patients on regular hemodialysis (HD). Objective: This work was carried out to eva
    
     
 
       

Author Related Publications

  • Ibrahiem Mohamed Ibrahim Salem, "Outcomes of Therapeutic Plasma Exchange; One Year Single Center Experience", international, 2016 More
  • Ibrahiem Mohamed Ibrahim Salem, "Reduced glomerular filtration rate as a predictor of coronary artery disease events in elderly patients", Elsevier, 2016 More
  • Ibrahiem Mohamed Ibrahim Salem, "Serum Leptin and Bone Mineral Density in Hemodialysis Patients with or without Liver Diseases", AJNT, 2011 More
  • Ibrahiem Mohamed Ibrahim Salem, "T-helper 1 Immune Response in Systemic Lupus Erythematosus and its Relation to Disease Activity", AJNT, 2009 More
  • Ibrahiem Mohamed Ibrahim Salem, "COMORBIDITY ASSESSMENT AND THYROID HORMONES IN INDEPENDENTLY-LIVING ELDERLY", Zagazig university, 2016 More

Department Related Publications

  • Mohamed Sedki Mohammed Yousuf, "The expression level of micro RNA-122 in patients with Type 2 Diabetes Mellitus in correlation with risk and severity of Coronary Artery Disease", مجلة محليه متخصصه, 2019 More
  • Ghada Mohamed Samir Ahmed, "Prevalence, risks and comorbidity of thyroid dysfunction: a cross-sectional epidemiological study", The Egyptian Journal of Internal Medicine, 2019 More
  • Mohammed Srour Mohammed Muhammed, "Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients", Wolters Kluwer Health, Inc., 2017 More
  • Amro Shaban Hanafy Elsayed, "Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients", Wolters Kluwer Health, Inc., 2017 More
  • Mohammed Ahmed Ali Bassiouni, "Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients", Wolters Kluwer Health, Inc., 2017 More
Tweet